Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2

Although oxaliplatin is an effective chemotherapeutic drug commonly used for colorectal cancer (CRC) treatment, drug resistance usually occurs during the long-term use of it. It is urgent to create strategies to reduce the resistance of CRC cells to oxaliplatin. Oxaliplatin-resistant CRC cells (OR-S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wei, Ge, Yang, Cui, Junpeng, Yu, Yifan, Liu, Baolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065260/
https://www.ncbi.nlm.nih.gov/pubmed/33981825
http://dx.doi.org/10.1016/j.omto.2021.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065260/
https://www.ncbi.nlm.nih.gov/pubmed/33981825
http://dx.doi.org/10.1016/j.omto.2021.03.010

Ejemplares similares